Deletion of Nrf2 Exacerbates Oxidative Stress After Traumatic Brain Injury in Mice

Xin-Yu Lu1, Han-Dong Wang, Jian-Guo Xu

  • 1Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, 210002, Jiangsu, China.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency worsens brain damage and oxidative stress after traumatic brain injury (TBI) in mice. Nrf2 plays a protective role in TBI by modulating oxidative stress.

Area of Science:

  • Neuroscience
  • Pathology
  • Molecular Biology

Background:

  • Traumatic brain injury (TBI) is a significant global health concern.
  • Oxidative stress is a key factor in TBI pathogenesis.
  • The role of Nuclear factor erythroid 2-related factor 2 (Nrf2) in TBI-induced brain damage requires further elucidation.

Purpose of the Study:

  • To investigate the protective effect of Nrf2 against oxidative stress and brain damage following TBI.
  • To analyze the impact of Nrf2 deletion on neurological deficits and brain edema in a mouse model of TBI.

Main Methods:

  • Adult male mice with and without Nrf2 expression (Nrf2(+/+) and Nrf2(-/-)) were subjected to a controlled weight-drop TBI model.
  • Neurological scores and brain edema (wet-dry ratio) were assessed 24 hours post-TBI.
  • Western blot and immunohistochemistry were used to evaluate NOX2 protein expression.
  • Malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were measured in brain tissues.

Main Results:

  • TBI induced more severe neurological deficits and brain edema in Nrf2(+/+) mice compared to sham controls.
  • Nrf2(-/-) TBI mice exhibited significantly exacerbated neurological deficits and brain edema compared to Nrf2(+/+) TBI mice.
  • Nrf2 deletion led to increased NOX2 protein and MDA levels, and decreased SOD activity post-TBI.

Conclusions:

  • Nrf2 deficiency exacerbates brain injury and oxidative stress following TBI in mice.
  • Nrf2 plays a critical neuroprotective role in TBI, likely through the modulation of oxidative stress pathways.
  • Targeting Nrf2 may represent a therapeutic strategy for mitigating TBI-induced brain damage.

Related Concept Videos